[ARS] Greenwich LifeSciences, Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

11/03/2025 - 05:11 PM

ARS - Greenwich LifeSciences, Inc.

ARS Filing - Greenwich LifeSciences, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Greenwich LifeSciences, Inc. (GLSI)

Acceptance Date: 2025-11-03T17:11:05.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Greenwich Lifesciences Inc

NASDAQ:GLSI

GLSI Rankings

#3790 Ranked by Market Cap

N/A Ranked by Dividends

GLSI Latest News

Dec 29, 2025

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Dec 22, 2025

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Dec 15, 2025

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Dec 8, 2025

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Dec 3, 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

GLSI Latest SEC Filings

Dec 18, 2025

[8-K] Greenwich LifeSciences, Inc. Reports Material Event

Nov 17, 2025

[Form 4] Greenwich LifeSciences, Inc. Insider Trading Activity

Nov 14, 2025

[10-Q] Greenwich LifeSciences, Inc. Quarterly Earnings Report

Nov 12, 2025

[Form 4] Greenwich LifeSciences, Inc. Insider Trading Activity

Nov 4, 2025

[Form 4] Greenwich LifeSciences, Inc. Insider Trading Activity

GLSI Stock Data

Market Cap 371.72M

Float 6.57M

Insiders Ownership 51.3%

Institutions Ownership 10.45%

Short Percent 7.87%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City STAFFORD